ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for VPRIV® 400 U:Takeda Pharma AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
A16AB10 - Velaglucerase AlfaATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A16 - Other Alimentary Tract and Metabolism Products
 
A16A - Other Alimentary Tract and Metabolism Products

This group comprises all products acting on the alimentary tract and metabolism which cannot be classified in the preceding groups. V03 - All other therapeutic products, should also be considered.
Nutrients are classified in V06 - General nutrients.

A16AB - Enzymes

This group includes gene therapy products resulting in the expression of specific enzymes.

A16AB10 - Velaglucerase Alfa
DoseRoute of administrationNote
 P 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home